Pancreatic Cancer Research

ResearcherUniversity of Tennessee Health Science CenterActive in the last 2 years

Sandeep Bobby Reddy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-7380-1761; OpenAlex author ID A5009091136. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancre… Co-author DOI 10.3389/fonc.2025.1472714↗
  2. Molecular profiling of a case of advanced pancreatic cancer identifies an active and tolerable combination of targeted therapy with backbone chemotherapy. Last author DOI 10.3978/j.issn.2078-6891.2015.091↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Patrick Soon‐Shiong · 1 shared paper, 2025 · strength 0.28
  2. Tara Elisabeth Seery · 1 shared paper, 2025 · strength 0.28
  3. Benny Johnson · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.